ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease

Cara Reiter-Brennan, Albert D. Osei, S. M. Iftekhar Uddin, Olusola A. Orimoloye, Olufunmilayo H. Obisesan, Mohammadhassan Mirbolouk, Michael J. Blaha, Omar Dzaye

Research output: Contribution to journalReview article

Abstract

The 2018 and 2019 guidelines from the American College of Cardiology and American Heart Association reflect the complexity of individualized cholesterol management. The documents address more detailed risk assessment, newer nonstatin cholesterol-lowering drugs, special attention to patient subgroups, and consideration of the value of therapy, all with the aim of creating personalized treatment plans for each patient. Overall, the guidelines recommend shared decision-making to meet the individual needs of each patient.

Original languageEnglish (US)
Pages (from-to)231-239
Number of pages9
JournalCleveland Clinic journal of medicine
Volume87
Issue number4
DOIs
StatePublished - Apr 1 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this

    Reiter-Brennan, C., Osei, A. D., Iftekhar Uddin, S. M., Orimoloye, O. A., Obisesan, O. H., Mirbolouk, M., Blaha, M. J., & Dzaye, O. (2020). ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease. Cleveland Clinic journal of medicine, 87(4), 231-239. https://doi.org/10.3949/ccjm.87a.19078